Promising gas therapies for severe COVID-19

The novel coronavirus disease 2019 (COVID-19) pandemic is a worldwide catastrophe, thoroughly challenging the healthcare systems. A growing number of victims suffer from a remarkable acute respiratory distress syndrome (ARDS) that necessitates admission to the intensive care unit (ICU), but there ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, Xiang, Qian, Bian, Jinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157123/
https://www.ncbi.nlm.nih.gov/pubmed/36943807
http://dx.doi.org/10.1016/j.jointm.2021.05.001
_version_ 1783699610313687040
author Wang, Ting
Xiang, Qian
Bian, Jinjun
author_facet Wang, Ting
Xiang, Qian
Bian, Jinjun
author_sort Wang, Ting
collection PubMed
description The novel coronavirus disease 2019 (COVID-19) pandemic is a worldwide catastrophe, thoroughly challenging the healthcare systems. A growing number of victims suffer from a remarkable acute respiratory distress syndrome (ARDS) that necessitates admission to the intensive care unit (ICU), but there are no satisfactory treatments. Various gas therapies including nitric oxide, ozone, hyperbaric oxygen, hydrogen, and heliox have been employed in the fight against the pandemic and have improved clinical outcomes. However, the potential roles of these gases in COVID-19 treatment need to be verified in well-designed randomized controlled trials. This paper reviews advances in gaseous therapy of COVID-19.
format Online
Article
Text
id pubmed-8157123
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81571232021-05-28 Promising gas therapies for severe COVID-19 Wang, Ting Xiang, Qian Bian, Jinjun J Intensive Med Perspective The novel coronavirus disease 2019 (COVID-19) pandemic is a worldwide catastrophe, thoroughly challenging the healthcare systems. A growing number of victims suffer from a remarkable acute respiratory distress syndrome (ARDS) that necessitates admission to the intensive care unit (ICU), but there are no satisfactory treatments. Various gas therapies including nitric oxide, ozone, hyperbaric oxygen, hydrogen, and heliox have been employed in the fight against the pandemic and have improved clinical outcomes. However, the potential roles of these gases in COVID-19 treatment need to be verified in well-designed randomized controlled trials. This paper reviews advances in gaseous therapy of COVID-19. Elsevier 2021-05-27 /pmc/articles/PMC8157123/ /pubmed/36943807 http://dx.doi.org/10.1016/j.jointm.2021.05.001 Text en © 2021 Chinese Medical Association. Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Perspective
Wang, Ting
Xiang, Qian
Bian, Jinjun
Promising gas therapies for severe COVID-19
title Promising gas therapies for severe COVID-19
title_full Promising gas therapies for severe COVID-19
title_fullStr Promising gas therapies for severe COVID-19
title_full_unstemmed Promising gas therapies for severe COVID-19
title_short Promising gas therapies for severe COVID-19
title_sort promising gas therapies for severe covid-19
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157123/
https://www.ncbi.nlm.nih.gov/pubmed/36943807
http://dx.doi.org/10.1016/j.jointm.2021.05.001
work_keys_str_mv AT wangting promisinggastherapiesforseverecovid19
AT xiangqian promisinggastherapiesforseverecovid19
AT bianjinjun promisinggastherapiesforseverecovid19

Ejemplares similares